Collste, K
Plavén-Sigray, P
Fatouros-Bergman, H
Victorsson, P
Schain, M
Forsberg, A
Amini, N
Aeinehband, S
L, Farde
L, Flyckt
G, Engberg
S, Erhardt
H, Fatouros-Bergman
S, Cervenka
L, Schwieler
F, Piehl
I, Agartz
K, Collste
P, Victorsson
A, Malmqvist
M, Hedberg
F, Orhan
Erhardt, S
Halldin, C
Flyckt, L
Farde, L
Cervenka, S
,
Article History
Received: 27 July 2016
Revised: 30 September 2016
Accepted: 22 November 2016
First Online: 14 February 2017
Competing interests
: LFa is an employee of AstraZeneca and affiliated with KI. SC has received grant support from AstraZeneca as a co-investigator, and has served as a one-off speaker for Roche and Otsuka Pharmaceuticals. SE has received grant support from AstraZeneca as the principal investigator, has served as a one-off speaker for Roche pharmaceuticals and participated in workshops organized by Otsuka Pharmaceuticals. The remaining authors declare no conflict of interest.